Decoding the role of angiopoietin-like protein 4/8 complex-mediated plasmin generation in the regulation of LPL activity.

angiopoietin-like protein (ANGPTL) apolipoprotein (Apo) lipoprotein lipase (LPL) plasmin plasminogen tissue plasminogen activator (tPA) triglycerides (TG)

Journal

Journal of lipid research
ISSN: 1539-7262
Titre abrégé: J Lipid Res
Pays: United States
ID NLM: 0376606

Informations de publication

Date de publication:
Oct 2023
Historique:
received: 09 07 2023
revised: 17 08 2023
accepted: 28 08 2023
pubmed: 5 9 2023
medline: 5 9 2023
entrez: 4 9 2023
Statut: ppublish

Résumé

After feeding, adipose tissue lipoprotein lipase (LPL) activity should be maximized, therefore the potent LPL-inhibitory activity of angiopoietin-like protein 4 (ANGPTL4) must be blocked by ANGPTL8 through formation of ANGPTL4/8 complexes. ANGPTL4/8 tightly binds and protects LPL but also partially inhibits its activity. Recently, we demonstrated ANGPTL4/8 also binds tissue plasminogen activator (tPA) and plasminogen to generate plasmin that cleaves ANGPTL4/8 to restore LPL activity. Although fully active LPL in the fat postprandially is desirable, ANGPTL4/8 removal could subject LPL to profound inhibition by ANGPTL3/8 (the most potent circulating LPL inhibitor), inhibition by other LPL inhibitors like ANGPTL4, ANGPTL3, and ApoC3 or interfere with ApoC2-mediated LPL activation. To understand better these potential paradoxes, we examined LPL inhibition by ANGPTL3/8, ANGPTL4, ANGPTL3, and ApoC3 and LPL stimulation by ApoC2 in the presence of ANGPTL4/8 + tPA + plasminogen. Remarkably, ANGPTL3/8-mediated LPL inhibition was almost completely blocked, with the mechanism being cleavage of fibrinogen-like domain-containing ANGPTL3 present in the ANGPTL3/8 complex. The LPL-inhibitory effects of ANGPTL4, ANGPTL3, and ApoC3 were also largely reduced in the presence of ANGPTL4/8 + tPA + plasminogen. In contrast, the ability of ApoC2 to stimulate LPL activity was unaffected by ANGPTL4/8-mediated plasmin generation. Together, these results explain how plasmin generated by increased postprandial ANGPTL4/8 levels in adipose tissue enables maximal LPL activity by preventing ANGPTL3/8, ANGPTL4, ANGPTL3, and ApoC3 from inhibiting LPL, while permitting ApoC2-mediated LPL activation to occur.

Identifiants

pubmed: 37666362
pii: S0022-2275(23)00114-1
doi: 10.1016/j.jlr.2023.100441
pmc: PMC10550811
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100441

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare no conflicts of interest with the contents of this article.

Auteurs

Yan Q Chen (YQ)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA.

Eugene Y Zhen (EY)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA.

Anna M Russell (AM)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA.

Mariam Ehsani (M)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA.

Robert W Siegel (RW)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA.

Yuewei Qian (Y)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA.

Robert J Konrad (RJ)

Lilly Research Laboratories, Eli Lilly, and Company, Indianapolis, IN, USA. Electronic address: konrad_robert@lilly.com.

Classifications MeSH